Log in to save to my catalogue

Neutralizing Activity of BNT162b2-Elicited Serum

Neutralizing Activity of BNT162b2-Elicited Serum

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7944950

Neutralizing Activity of BNT162b2-Elicited Serum

About this item

Full title

Neutralizing Activity of BNT162b2-Elicited Serum

Publisher

United States: Massachusetts Medical Society

Journal title

The New England journal of medicine, 2021-04, Vol.384 (15), p.1466-1468

Language

English

Formats

Publication information

Publisher

United States: Massachusetts Medical Society

More information

Scope and Contents

Contents

How well do serum samples obtained from persons injected with the BNT162b2 vaccine neutralize the P.1, B.1.1.7, and B.1.135 lineages of SARS-CoV-2, first identified in Brazil, Britain, and South Africa, respectively? This study provides an answer.

Alternative Titles

Full title

Neutralizing Activity of BNT162b2-Elicited Serum

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7944950

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7944950

Other Identifiers

ISSN

0028-4793

E-ISSN

1533-4406

DOI

10.1056/NEJMc2102017

How to access this item